[Preliminary experiences in the treatment of onychomycosis with ketoconazole].
17 patients with proven onychomycosis were treated with Ketoconazole (200 mg daily) over 6 months. In 15, a distinct improvement was seen, 2 were slightly improved. No therapeutic failures were to be seen. Few patients complained about side effects; biochemical parameters were neither consistently changed, nor caused discontinuing of treatment.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002175:Candida; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D007654:Ketoconazole; D008875:Middle Aged; D014009:Onychomycosis / Q000188:drug therapy* / Q000209:etiology; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use*; D014249:Trichophyton
D000935:Antifungal Agents; D007093:Imidazoles; D010879:Piperazines; D007654:Ketoconazole
Erste Erfahrungen bei der Behandlung der Onychomykjose mit Ketoconazol.